Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
CONCLUSIONS: Premenopausal Mexican women self-report remarkably high rates of adequate ET adherence. However, a considerable proportion misses ≥1 doses/month, usually because of forgetfulness. Notably, only 64% receive standard-of-care ET due to suboptimal prescription of OFS. Interventions that remind patients to take their ET, refine physicians' knowledge on the importance of OFS in high-risk patients, and increase access to OFS could prove pivotal to enhance optimal ET implementation and adherence, which could translate into improved patient outcomes.PMID:34116366 | DOI:10.1016/j.breast.2021.05.013
Source: Breast - Category: Cancer & Oncology Authors: Cynthia Villarreal-Garza Fernanda Mesa-Chavez Ana S Ferrigno Cynthia De la Garza-Ramos Alan Fonseca Karen Villanueva-Tamez Jose Y Campos-Salgado Marlid Cruz-Ramos David O Rodriguez-Gomez Sandy Ruiz-Cruz Paula Cabrera-Galeana Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Hormones | Mexico Health | Ovarian Cancer | Ovaries | Study | Tamoxifen | Women